COGT
Cogent Biosciences, Inc.
Stock
$31.02−0.57 (−1.80%)Close Oct 2, 2026
- Capital expenditures, 2025
- $1.6M
- YoY, 2025
- +171.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.6M | +171.2% |
| 2024 | $573K | −79.5% |
| 2023 | $2.8M | −59.3% |
| 2022 | $6.9M | +299.2% |
| 2021 | $1.7M | — |
| 2019 | $33K | −94.0% |
| 2018 | $549K | −39.8% |
| 2017 | $912K | — |